Inovio Pharma (INO) Misses Q4 EPS by $1.13

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Inovio Pharma (INO) Misses Q4 EPS by $1.13

Inovio Pharmaceuticals (INO) PT Lowered to $30 at Oppenheimer

March 2, 2022 12:56 PM EST

Oppenheimer analyst Hartaj Singh lowered the price target on Inovio Pharmaceuticals (NASDAQ: INO) to $30.00 (from $35.00) while maintaining an Outperform rating after the company provided a business and pipeline update to investors on 3/1.

The analyst commented, "While the company reported steady progress, the... More